Dr Stephen Palmer is a Program Director at Novogen Ltd and Conjoint Senior Lecturer at UNSW Australia. He is a former member of the Cellular and Genetic Medicine Unit in the School of Medical Sciences with research interests in understanding the role of the gene GTF2IRD1 in brain development and human behaviour and its contribution towards the characteristic features of Williams-Beuren syndrome.
Stephen Palmer completed his PhD at University College London in 1992 and was awarded an MRC Postdoctoral Training Fellowship to work with Alan Ashworth at the Institute of Cancer Research. In 1997, he came to Australia on a Wellcome Trust International Travelling Fellowship, to work with Richard Harvey at the Victor Chang Cardiac Research Institute. After a brief spell back in the UK, Stephen returned to Australia in 2002, joining Edna Hardeman at the Children's Medical Research Institute and then on to UNSW Australia in 2009.
Skills include: drug development, cell biology, biochemistry, gene regulation, embryology, genetics and mouse models of disease